<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="082774-2018"
            EDITION="2018038">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-085445-001</RECEPTION_ID>
      <DELETION_DATE>20180602</DELETION_DATE>
      <FORM_LG_LIST>ES </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>38</NO_OJ>
         <DATE_PUB>20180223</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 038-082774</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="ES">http://ted.europa.eu/udl?uri=TED:NOTICE:082774-2018:TEXT:ES:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>ES</LG_ORIG>
         <ISO_COUNTRY VALUE="ES"/>
         <IA_URL_GENERAL>www.santpau.cat</IA_URL_GENERAL>
         <ORIGINAL_CPV CODE="33690000">Various medicinal products</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="ES511">Barcelona</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="ES511">Barcelona</n2016:CA_CE_NUTS>
         <n2016:TENDERER_NUTS CODE="ES511">Barcelona</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="ES300">Madrid</n2016:TENDERER_NUTS>
         <VALUES>
            <VALUE TYPE="PROCUREMENT_TOTAL" CURRENCY="EUR">60091356.09</VALUE>
         </VALUES>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180222</DS_DATE_DISPATCH>
         <AA_AUTHORITY_TYPE CODE="8">Other</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="T">Negotiated without a prior call for competition</PR_PROC>
         <RP_REGULATION CODE="4">European Union</RP_REGULATION>
         <TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="1">Lowest price</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES>
         <HEADING>01B03</HEADING>
         <INITIATOR>01</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Иcпaния</TI_CY>
            <TI_TOWN>Барселона</TI_TOWN>
            <TI_TEXT>
               <P>Разни медикаменти</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Španělsko</TI_CY>
            <TI_TOWN>Barcelona</TI_TOWN>
            <TI_TEXT>
               <P>Různé léčivé přípravky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Spanien</TI_CY>
            <TI_TOWN>Barcelona</TI_TOWN>
            <TI_TEXT>
               <P>Diverse lægemidler</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>Spanien</TI_CY>
            <TI_TOWN>Barcelona</TI_TOWN>
            <TI_TEXT>
               <P>Varia</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Ισπανία</TI_CY>
            <TI_TOWN>Βαρκελώνη</TI_TOWN>
            <TI_TEXT>
               <P>Διάφορα φάρμακα</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>Spain</TI_CY>
            <TI_TOWN>Barcelona</TI_TOWN>
            <TI_TEXT>
               <P>Various medicinal products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>España</TI_CY>
            <TI_TOWN>Barcelona</TI_TOWN>
            <TI_TEXT>
               <P>Medicamentos diversos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Hispaania</TI_CY>
            <TI_TOWN>Barcelona</TI_TOWN>
            <TI_TEXT>
               <P>Mitmesugused ravimid</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Espanja</TI_CY>
            <TI_TOWN>Barcelona</TI_TOWN>
            <TI_TEXT>
               <P>Muut lääkkeet</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>Espagne</TI_CY>
            <TI_TOWN>Barcelone</TI_TOWN>
            <TI_TEXT>
               <P>Médicaments divers</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Spáinn, an</TI_CY>
            <TI_TOWN>Barcelona</TI_TOWN>
            <TI_TEXT>
               <P>Various medicinal products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Španjolska</TI_CY>
            <TI_TOWN>Barcelona</TI_TOWN>
            <TI_TEXT>
               <P>Razni lijekovi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Spanyolország</TI_CY>
            <TI_TOWN>Barcelona</TI_TOWN>
            <TI_TEXT>
               <P>Különböző gyógyszerek</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Spagna</TI_CY>
            <TI_TOWN>Barcellona</TI_TOWN>
            <TI_TEXT>
               <P>Medicinali vari</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Ispanija</TI_CY>
            <TI_TOWN>Barselona</TI_TOWN>
            <TI_TEXT>
               <P>Kiti vaistai</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Spānija</TI_CY>
            <TI_TOWN>Barselona</TI_TOWN>
            <TI_TEXT>
               <P>Dažādas zāles</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>Spanja</TI_CY>
            <TI_TOWN>Barċellona</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti mediċinali varji</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Spanje</TI_CY>
            <TI_TOWN>Barcelona</TI_TOWN>
            <TI_TEXT>
               <P>Diverse geneesmiddelen</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Hiszpania</TI_CY>
            <TI_TOWN>Barcelona</TI_TOWN>
            <TI_TEXT>
               <P>Różne produkty lecznicze</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>Espanha</TI_CY>
            <TI_TOWN>Barcelona</TI_TOWN>
            <TI_TEXT>
               <P>Medicamentos vários</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Spania</TI_CY>
            <TI_TOWN>Barcelona</TI_TOWN>
            <TI_TEXT>
               <P>Diverse medicamente</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Španielsko</TI_CY>
            <TI_TOWN>Barcelona</TI_TOWN>
            <TI_TEXT>
               <P>Rôzne liečivá</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Španija</TI_CY>
            <TI_TOWN>Barcelona</TI_TOWN>
            <TI_TEXT>
               <P>Različna zdravila</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Spanien</TI_CY>
            <TI_TOWN>Barcelona</TI_TOWN>
            <TI_TEXT>
               <P>Varia</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="ES">Fundación de Gestión Sanitaria del Hospital de la Santa Creu i Sant Pau</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <F03_2014 CATEGORY="ORIGINAL" FORM="F03" LG="ES">
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>Fundación de Gestión Sanitaria del Hospital de la Santa Creu i Sant Pau</OFFICIALNAME>
               <ADDRESS>C/ Sant Antoni Mª Claret, 167, Pabellón Sant Antoni, planta baja</ADDRESS>
               <TOWN>Barcelona</TOWN>
               <POSTAL_CODE>08025</POSTAL_CODE>
               <COUNTRY VALUE="ES"/>
               <PHONE>+34 935537621</PHONE>
               <E_MAIL>contractacions@santpau.cat</E_MAIL>
               <FAX>+34 935537631</FAX>
               <n2016:NUTS CODE="ES511"/>
               <URL_GENERAL>www.santpau.cat</URL_GENERAL>
               <URL_BUYER>https://contractaciopublica.gencat.cat/ecofin_pscp/AppJava/cap.pscp?reqCode=viewDetail&amp;keyword=sant+pau&amp;idCap=4373006&amp;ambit=&amp;</URL_BUYER>
            </ADDRESS_CONTRACTING_BODY>
            <CA_TYPE_OTHER>Poder adjudicador no Administración pública</CA_TYPE_OTHER>
            <CA_ACTIVITY VALUE="HEALTH"/>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT>
            <TITLE>
               <P>Tercer suministro de fármacos exclusivos</P>
            </TITLE>
            <REFERENCE_NUMBER>OBE 17/279</REFERENCE_NUMBER>
            <CPV_MAIN>
               <CPV_CODE CODE="33690000"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>Tercer suministro de fármacos exclusivos.</P>
            </SHORT_DESCR>
            <VAL_TOTAL CURRENCY="EUR">60091356.09</VAL_TOTAL>
            <LOT_DIVISION/>
            <OBJECT_DESCR ITEM="1">
               <TITLE>
                  <P>Fármacos exclusivos sociedad Alexion Pharma Spain, S. L.</P>
               </TITLE>
               <LOT_NO>1</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos exclusivos sociedad Alexion Pharma Spain, S. L.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="2">
               <TITLE>
                  <P>Fármacos exclusivos sociedad Allergan, S. A.</P>
               </TITLE>
               <LOT_NO>2</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos exclusivos sociedad Allergan, S. A.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="3">
               <TITLE>
                  <P>Fármacos exclusivos AstraZeneca Farmacéutica Spain</P>
               </TITLE>
               <LOT_NO>3</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos exclusivos AstraZeneca Farmacéutica Spain.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="4">
               <TITLE>
                  <P>Fármacos exclusivos Baxter, S. L.</P>
               </TITLE>
               <LOT_NO>4</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos exclusivos Baxter, S. L.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="5">
               <TITLE>
                  <P>Fármacos exclusivos Biogen Spain, S. L.</P>
               </TITLE>
               <LOT_NO>5</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos exclusivos Biogen Spain, S. L.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="6">
               <TITLE>
                  <P>Fármacos exclusivos Boehringer Ingelheim España, S. A.</P>
               </TITLE>
               <LOT_NO>6</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos exclusivos Boehringer Ingelheim España, S. A.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="7">
               <TITLE>
                  <P>Fármacos exclusivos Guerbet Imaging Spain, S. L.</P>
               </TITLE>
               <LOT_NO>7</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos exclusivos Guerbet Imaging Spain, S. L.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="8">
               <TITLE>
                  <P>Fármacos exclusivos Eisai Farmacéutica, S. A.</P>
               </TITLE>
               <LOT_NO>8</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos exclusivos Eisai Farmacéutica, S. A.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="9">
               <TITLE>
                  <P>Fármacos exclusivos Fresenius Kabi España, S. A. U.</P>
               </TITLE>
               <LOT_NO>9</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos exclusivos Fresenius Kabi España, S. A. U.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="10">
               <TITLE>
                  <P>Fármacos exclusivos Ipsen Pharma, S. A.</P>
               </TITLE>
               <LOT_NO>10</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos exclusivos Ipsen Pharma, S. A.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="11">
               <TITLE>
                  <P>Fármacos exclusivos Italfarmaco, S. A.</P>
               </TITLE>
               <LOT_NO>11</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos exclusivos Italfarmaco, S. A.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="12">
               <TITLE>
                  <P>Fármacos exclusivos Kern Pharma, S. L.</P>
               </TITLE>
               <LOT_NO>12</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos exclusivos Kern Pharma, S. L.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="13">
               <TITLE>
                  <P>Fármacos exclusivos Laboratorios Thea, S. A.</P>
               </TITLE>
               <LOT_NO>13</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos exclusivos Laboratorios Thea, S. A.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="14">
               <TITLE>
                  <P>Fármacos exclusivos Lilly, S. A.</P>
               </TITLE>
               <LOT_NO>14</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos exclusivos Lilly, S. A.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="15">
               <TITLE>
                  <P>Fármacos exclusivos Merck, S. L. U.</P>
               </TITLE>
               <LOT_NO>15</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos exclusivos Merck, S. L. U.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="16">
               <TITLE>
                  <P>Fármacos exclusivos Novartis Farmacéutica, S. A.</P>
               </TITLE>
               <LOT_NO>16</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos exclusivos Novartis Farmacéutica, S. A.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="17">
               <TITLE>
                  <P>Fármacos exclusivos Novo Nordisk Pharma, S. A.</P>
               </TITLE>
               <LOT_NO>17</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos exclusivos Novo Nordisk Pharma, S. A.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="18">
               <TITLE>
                  <P>Fármacos exclusivos Orion Pharma, S. L.</P>
               </TITLE>
               <LOT_NO>18</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos exclusivos Orion Pharma, S. L.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="19">
               <TITLE>
                  <P>Fármacos exclusivos Otsuka Pharmaceutical, S. A.</P>
               </TITLE>
               <LOT_NO>19</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos exclusivos Otsuka Pharmaceutical, S. A.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="20">
               <TITLE>
                  <P>Fármacos exclusivos Pfizer, S. L. U.</P>
               </TITLE>
               <LOT_NO>20</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos exclusivos Pfizer, S. L. U.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="21">
               <TITLE>
                  <P>Fármacos exclusivos Pfizer Gep, S. L. U.</P>
               </TITLE>
               <LOT_NO>21</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos exclusivos Pfizer Gep, S. L. U.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="22">
               <TITLE>
                  <P>Fármacos exclusivos Sanofi-Aventis, S. A.</P>
               </TITLE>
               <LOT_NO>22</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos exclusivos Sanofi-Aventis, S. A.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="23">
               <TITLE>
                  <P>Fármacos exclusivos Laboratorios Servier, S. L.</P>
               </TITLE>
               <LOT_NO>23</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos exclusivos Laboratorios Servier, S. L.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="24">
               <TITLE>
                  <P>Fármacos exclusivos Shire Pharmaceuticals Ibérica, S. L.</P>
               </TITLE>
               <LOT_NO>24</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos exclusivos Shire Pharmaceuticals Ibérica, S. L.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="25">
               <TITLE>
                  <P>Fármacos exclusivos Takeda Farmacéutica, S. A.</P>
               </TITLE>
               <LOT_NO>25</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos exclusivos Takeda Farmacéutica, S. A.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="26">
               <TITLE>
                  <P>Fármacos exclusivos Teva Pharma, S. L. U.</P>
               </TITLE>
               <LOT_NO>26</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos exclusivos Teva Pharma, S. L. U.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="27">
               <TITLE>
                  <P>Fármacos Exclusivos UCB Pharma, S. A.</P>
               </TITLE>
               <LOT_NO>27</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos Exclusivos UCB Pharma, S. A.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="28">
               <TITLE>
                  <P>Fármacos exclusivos Bristol-Myers Squibb, S. A. U.</P>
               </TITLE>
               <LOT_NO>28</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos exclusivos Bristol-Myers Squibb, S. A. U.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="29">
               <TITLE>
                  <P>Fármacos exclusivos Merck Sharp &amp; Dohme de España, S. A.</P>
               </TITLE>
               <LOT_NO>29</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES511"/>
               <SHORT_DESCR>
                  <P>Fármacos exclusivos Merck Sharp &amp; Dohme de España, S. A.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
         </OBJECT_CONTRACT>
         <PROCEDURE>
            <PT_AWARD_CONTRACT_WITHOUT_CALL>
               <D_ACCORDANCE_ARTICLE>
                  <D_PROTECT_RIGHTS/>
               </D_ACCORDANCE_ARTICLE>
               <D_JUSTIFICATION>
                  <P>El procedimiento se ha tramitado mediante procedimiento negociado sin publicidad, dando cumplimiento a lo que establece el articulo 32 de la Directiva 2014/24/UE, el articulo 170 d) del TRLCSP y según instrucciones internas de contratación.</P>
               </D_JUSTIFICATION>
            </PT_AWARD_CONTRACT_WITHOUT_CALL>
            <NO_CONTRACT_COVERED_GPA/>
         </PROCEDURE>
         <AWARD_CONTRACT ITEM="1">
            <CONTRACT_NO>1</CONTRACT_NO>
            <LOT_NO>1</LOT_NO>
            <TITLE>
               <P>Fármacos exclusivos Alexion Pharma Spain, S. L.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Alexion Pharma Spain, S. L.</OFFICIALNAME>
                     <TOWN>Barcelona</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES511"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">773766.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">773766.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="2">
            <CONTRACT_NO>2</CONTRACT_NO>
            <LOT_NO>2</LOT_NO>
            <TITLE>
               <P>Fármacos exclusivos Allergan, S. A.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Allergan, S. A.</OFFICIALNAME>
                     <TOWN>Tres Cantos</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES300"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">1055376.96</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">1055376.96</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="3">
            <CONTRACT_NO>3</CONTRACT_NO>
            <LOT_NO>3</LOT_NO>
            <TITLE>
               <P>Fármacos exclusivos AstraZeneca Farmacéutica Spain</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>AstraZeneca Farmacéutica Spain</OFFICIALNAME>
                     <TOWN>Madrid</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES300"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">950141.49</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">950141.49</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="4">
            <CONTRACT_NO>4</CONTRACT_NO>
            <LOT_NO>4</LOT_NO>
            <TITLE>
               <P>Fármacos exclusivos Baxter, S. L.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Baxter, S. L.</OFFICIALNAME>
                     <TOWN>San Fernando de Henares</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES300"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">903839.13</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">903839.13</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="5">
            <CONTRACT_NO>5</CONTRACT_NO>
            <LOT_NO>5</LOT_NO>
            <TITLE>
               <P>Fármacos exclusivos Biogen Spain, S. L.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Biogen Spain, S. L.</OFFICIALNAME>
                     <TOWN>Madrid</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES300"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">159143.10</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">159143.10</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="6">
            <CONTRACT_NO>6</CONTRACT_NO>
            <LOT_NO>6</LOT_NO>
            <TITLE>
               <P>Fármacos exclusivos Boehringer Ingelheim España, S. A.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Boehringer Ingelheim España, S. A.</OFFICIALNAME>
                     <TOWN>Sant Cugat del Vallès</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES511"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">894127.05</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">886127.61</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="7">
            <CONTRACT_NO>7</CONTRACT_NO>
            <LOT_NO>7</LOT_NO>
            <TITLE>
               <P>Fármacos exclusivos Guerbet Imaging Spain, S. L.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Guerbet Imaging Spain, S. L.</OFFICIALNAME>
                     <TOWN>Madrid</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES300"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">865027.95</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">865027.95</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="8">
            <CONTRACT_NO>8</CONTRACT_NO>
            <LOT_NO>8</LOT_NO>
            <TITLE>
               <P>Fármacos exclusivos Eisai Farmacéutica, S. A.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Eisai Farmacéutica, S. A.</OFFICIALNAME>
                     <TOWN>Madrid</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES300"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">829008.96</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">829008.96</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="9">
            <CONTRACT_NO>9</CONTRACT_NO>
            <LOT_NO>9</LOT_NO>
            <TITLE>
               <P>Fármacos exclusivos Fresenius Kabi España, S. A. U.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Fresenius Kabi España, S. A. U.</OFFICIALNAME>
                     <TOWN>Barcelona</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES511"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">194224.20</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">194224.20</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="10">
            <CONTRACT_NO>10</CONTRACT_NO>
            <LOT_NO>10</LOT_NO>
            <TITLE>
               <P>Fármacos exclusivos Ipsen Pharma, S. A.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Ipsen Pharma, S. A.</OFFICIALNAME>
                     <TOWN>L'Hospitalet de Llobregat</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES511"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">189441.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">189441.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="11">
            <CONTRACT_NO>11</CONTRACT_NO>
            <LOT_NO>11</LOT_NO>
            <TITLE>
               <P>Fármacos exclusivos Italfarmaco, S. A.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Italfarmaco, S. A.</OFFICIALNAME>
                     <TOWN>Alcobendas</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES300"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">114126.27</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">114126.27</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="12">
            <CONTRACT_NO>12</CONTRACT_NO>
            <LOT_NO>12</LOT_NO>
            <TITLE>
               <P>Fármacos exclusivos Kern Pharma, S. L.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Kern Pharma, S. L.</OFFICIALNAME>
                     <TOWN>Terrassa</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES511"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">508561.77</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">501206.01</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="13">
            <CONTRACT_NO>13</CONTRACT_NO>
            <LOT_NO>13</LOT_NO>
            <TITLE>
               <P>Fármacos exclusivos Laboratorios Thea, S. A.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Laboratorios Thea, S. A.</OFFICIALNAME>
                     <TOWN>Madrid</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES300"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">80629.50</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">80629.50</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="14">
            <CONTRACT_NO>14</CONTRACT_NO>
            <LOT_NO>14</LOT_NO>
            <TITLE>
               <P>Fármacos exclusivos Lilly, S. A.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Lilly, S. A.</OFFICIALNAME>
                     <TOWN>Alcobendas</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES300"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">2140335.96</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">2140335.96</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="15">
            <CONTRACT_NO>15</CONTRACT_NO>
            <LOT_NO>15</LOT_NO>
            <TITLE>
               <P>Fármacos exclusivos Merck, S. L. U.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Merck, S. L. U.</OFFICIALNAME>
                     <TOWN>Madrid</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES300"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">3128822.28</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">3128733.18</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="16">
            <CONTRACT_NO>16</CONTRACT_NO>
            <LOT_NO>16</LOT_NO>
            <TITLE>
               <P>Fármacos exclusivos Novartis Farmacéutica, S. A.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Novartis Farmacéutica, S. A.</OFFICIALNAME>
                     <TOWN>Barcelona</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES511"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">13533437.70</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">12974330.40</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="17">
            <CONTRACT_NO>17</CONTRACT_NO>
            <LOT_NO>17</LOT_NO>
            <TITLE>
               <P>Fármacos exclusivos Novo Nordisk Pharma, S. A.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Novo Nordisk Pharma, S. A.</OFFICIALNAME>
                     <TOWN>Madrid</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES300"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">296991.36</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">296991.36</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="18">
            <CONTRACT_NO>18</CONTRACT_NO>
            <LOT_NO>18</LOT_NO>
            <TITLE>
               <P>Fármacos exclusivos Orion Pharma, S. L.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Orion Pharma, S. L.</OFFICIALNAME>
                     <TOWN>Madrid</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES300"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">460140.03</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">460140.03</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="19">
            <CONTRACT_NO>19</CONTRACT_NO>
            <LOT_NO>19</LOT_NO>
            <TITLE>
               <P>Fármacos exclusivos Otsuka Pharmaceutical, S. A.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Otsuka Pharmaceutical, S. A.</OFFICIALNAME>
                     <TOWN>Barcelona</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES511"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">127265.76</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">127265.76</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="20">
            <CONTRACT_NO>20</CONTRACT_NO>
            <LOT_NO>20</LOT_NO>
            <TITLE>
               <P>Fármacos exclusivos Pfizer, S. L. U.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Pfizer, S. L. U.</OFFICIALNAME>
                     <TOWN>Alcobendas</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES300"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">6586626.63</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">6584157.03</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="21">
            <CONTRACT_NO>21</CONTRACT_NO>
            <LOT_NO>21</LOT_NO>
            <TITLE>
               <P>Fármacos exclusivos Pfizer Gep, S. L. U.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Pfizer Gep, S. L. U.</OFFICIALNAME>
                     <TOWN>Alcobendas</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES300"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">530559.60</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">502093.68</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="22">
            <CONTRACT_NO>22</CONTRACT_NO>
            <LOT_NO>22</LOT_NO>
            <TITLE>
               <P>Fármacos exclusivos Sanofi-Aventis, S. A.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Sanofi-Aventis, S. A.</OFFICIALNAME>
                     <TOWN>Madrid</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES300"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">3849752.49</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">3792389.07</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="23">
            <CONTRACT_NO>23</CONTRACT_NO>
            <LOT_NO>23</LOT_NO>
            <TITLE>
               <P>Fármacos exclusivos Laboratorios Servier, S. L.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Laboratorios Servier, S. L.</OFFICIALNAME>
                     <TOWN>Madrid</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES300"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">193184.85</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">193184.85</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="24">
            <CONTRACT_NO>24</CONTRACT_NO>
            <LOT_NO>24</LOT_NO>
            <TITLE>
               <P>Fármacos exclusivos Shire Pharmaceuticals Ibérica, S. L.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Shire Pharmaceuticals Ibérica, S. L.</OFFICIALNAME>
                     <TOWN>Madrid</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES300"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">1599639.57</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">1599639.57</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="25">
            <CONTRACT_NO>25</CONTRACT_NO>
            <LOT_NO>25</LOT_NO>
            <TITLE>
               <P>Fármacos exclusivos Takeda Farmacéutica, S. A.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Takeda Farmacéutica, S. A.</OFFICIALNAME>
                     <TOWN>Madrid</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES300"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">1356644.82</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">1356644.82</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="26">
            <CONTRACT_NO>26</CONTRACT_NO>
            <LOT_NO>26</LOT_NO>
            <TITLE>
               <P>Fármacos exclusivos Teva Pharma, S. L. U.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Teva Pharma, S. L. U.</OFFICIALNAME>
                     <TOWN>Madrid</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES300"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">1123571.01</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">1123369.26</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="27">
            <CONTRACT_NO>27</CONTRACT_NO>
            <LOT_NO>27</LOT_NO>
            <TITLE>
               <P>Fármacos Exclusivos UCB Pharma, S. A.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>UCB Pharma, S. A.</OFFICIALNAME>
                     <TOWN>Madrid</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES300"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">935654.04</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">935654.04</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="28">
            <CONTRACT_NO>28</CONTRACT_NO>
            <LOT_NO>28</LOT_NO>
            <TITLE>
               <P>Fármacos exclusivos Bristol-Myers Squibb, S. A. U.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-20</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Bristol-Myers Squibb, S. A. U.</OFFICIALNAME>
                     <TOWN>Madrid</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES300"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">4296899.73</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">4243046.61</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="29">
            <CONTRACT_NO>29</CONTRACT_NO>
            <LOT_NO>29</LOT_NO>
            <TITLE>
               <P>Fármacos exclusivos Merck Sharp &amp; Dohme de España, S. A.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Merck Sharp &amp; Dohme de España, S. A.</OFFICIALNAME>
                     <TOWN>Madrid</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES300"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">12414416.88</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">12368597.64</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <COMPLEMENTARY_INFO>
            <ADDRESS_REVIEW_BODY>
               <OFFICIALNAME>Tribunal Català de Contractes del Sector Públic</OFFICIALNAME>
               <TOWN>Barcelona</TOWN>
               <COUNTRY VALUE="ES"/>
            </ADDRESS_REVIEW_BODY>
            <ADDRESS_MEDIATION_BODY>
               <OFFICIALNAME>No procede</OFFICIALNAME>
               <TOWN>Barcelona</TOWN>
               <COUNTRY VALUE="ES"/>
            </ADDRESS_MEDIATION_BODY>
            <DATE_DISPATCH_NOTICE>2018-02-22</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F03_2014>
   </FORM_SECTION>
</TED_EXPORT>
